Guasparri et al reported that EBV LMP2A protein could affect LMP1-mediated NF-κB signaling and survival of lymphoma cells [46], hence LMP2A might increase miR-155 expression through the NF- kappaB pathway. Here, NFKB1 is linked to lymphoma.